References
- FrierBMFisherMDiabetes mellitusColledgeNRWalkerBRRalstonSHDavidsons’s Principles and Practice of Medicine21st edNew York, NY, USAChurchill Livingstone Elsevier2010
- International Diabetes FederationIDF Diabetes Atlas6th ed2013 Available from: http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdfAccessed June 25, 2015
- WildSRoglicGGreenASicreeRKingHGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Diabetes Care20042751047 105315111519
- MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
- StolarMGlycemic control and complications in type 2 diabetes mellitusAm J Med20101233 SupplS3 S1120206730
- BrunzellJDDavidsonMFurbergCDLipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology FoundationDiabetes Care2008314811 82218375431
- BaysHEChapmanRHGrandySThe relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveysInt J Clin Pract2007615737 74717493087
- Lloyd-JonesDAdamsRCarnethonMHeart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation20091193e21 e18119075105
- KvanEPettersenKISandvikLReikvamAHigh mortality in diabetic patients with acute myocardial infarction: cardiovascular co-morbidities contribute most to the high riskInt J Cardiol20071212184 18817184858
- MorrishNJWangSLStevensLKFullerJHKeenHMortality and causes of death in the WHO Multinational Study of Vascular Disease in DiabetesDiabetologia200144Suppl 2S14 S2111587045
- MendisSPuskaPNorrvingBGlobal Atlas on Cardiovascular Disease Prevention and ControlGeneva, SwitzerlandWorld Health Organization2011
- SchultzDRArnoldPIProperties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogenSemin Arthritis Rheum1990203129 1471705051
- PepysMBHirschfieldGMC-reactive protein: a critical updateJ Clin Invest2003111121805 181212813013
- HageFGSzalaiAJC-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease riskJ Am Coll Cardiol200750121115 112217868801
- MurrayRKBenderDABothamKMKennellyPJRodwellVWWeilPAHarper’s Illustrated Biochemistry28th edNew York, NY, USAMcGraw-Hill Companies2009
- RidkerPMRifaiNRoseLBuringJECookNRComparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular eventsN Engl J Med2002347201557 156512432042
- SuSCPeiDHsiehCHHsiaoFCWuCZHungYJCirculating pro-inflammatory cytokines and adiponectin in young men with type 2 diabetesActa Diabetol2011482113 11920058158
- de RekeneireNPeilaRDingJDiabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition studyDiabetes Care20062981902 190816873800
- WaheedPNaveedAKFarooqFLevels of inflammatory markers and their correlation with dyslipidemia in diabeticsJ Coll Physicians Surg Pak2009194207 21019356332
- BertoniAGBurkeGLOwusuJAInflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)Diabetes Care2010334804 81020097779
- BelfkiHBen AliSBougatefSAssociation between C-reactive protein and type 2 diabetes in a Tunisian populationInflammation2012352684 68921769439
- EhiagheAFAgbonlahorDETatfengYMOnikepeFOviasogieFEEhiagheJISerum C reactive protein level in type 2 diabetes mellitus patients attending diabetic clinic in Benin City, NigeriaJournal of Diabetes Mellitus20132013
- MisraDPDasSSahuPKPrevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-kappaB, and adi-ponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complicationsMetab Syndr Relat Disord2012103209 21322316266
- BarzilayJIAbrahamLHeckbertSRThe relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health StudyDiabetes200150102384 238911574423
- HuFBMeigsJBLiTYRifaiNMansonJEInflammatory markers and risk of developing type 2 diabetes in womenDiabetes2004533693 70014988254
- TabakAGKivimakiMBrunnerEJChanges in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II studyEur J Endocrinol2010163189 9520573938
- SamSHaffnerSDavidsonMHRelation of abdominal fat depots to systemic markers of inflammation in type 2 diabetesDiabetes Care2009325932 93719228869
- American Diabetes AssociationStandards of medical care in diabetesDiabetes Care200528Suppl 1S4 S3615618112
- NguyenNTMagnoCPLaneKTHinojosaMWLaneJSAssociation of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004J Am Coll Surg20082076928 93419183541
- AbdullahAPeetersAde CourtenMStoelwinderJThe magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studiesDiabetes Res Clin Pract2010893309 31920493574
- Del PratoSEnziGVigili de KreutzenbergSInsulin regulation of glucose and lipid metabolism in massive obesityDiabetologia1990334228 2362189770
- SchusterDPObesity and the development of type 2 diabetes: the effects of fatty tissue inflammationDiabetes Metab Syndr Obes20103253 26221437093
- ConnellyPWHanleyAJHarrisSBHegeleRAZinmanBRelation of waist circumference and glycemic status to C-reactive protein in the Sandy Lake Oji-CreeInt J Obes Relat Metab Disord2003273347 35412629562
- BabaMMKolawoleBAlkemRTArogundadeFAYusuphHGezawaIDSerum C-reactive protein in Nigerians with type 2 diabetes mellitusNiger J Med2010194427 43121526633
- NabipourIVahdatKJafariSMElevated high sensitivity C-reactive protein is associated with type 2 diabetes mellitus: the Persian Gulf Healthy Heart StudyEndocr J2008554717 72218493107
- SabanayagamCShankarALimSCLeeJTaiESWongTYSerum C-reactive protein level and prediabetes in two Asian populationsDiabetologia2011544767 77521267537
- ChoiJJosephLPiloteLObesity and C-reactive protein in various populations: a systematic review and meta-analysisObes Rev2013143232 24423171381
- ZhaoYLvGCorrelation of C-reactive protein level and obesity in Chinese adults and children: a meta-analysisJ Endocrinol Invest2013368642 64723765545
- HuffmanFGWhisnerSZariniGGNathSWaist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetesInt J Environ Res Public Health201073842 85220617007
- ZaciragicAHuskicJHadzovic-DzuvoAValjevacAAvdagicNMulabegovicNSerum C-reactive protein concentration and measures of adiposity in patients with type 2 diabetes mellitusBosn J Basic Med Sci200774322 32718039190
- BabaMMBalogunMOKolawoleBAIkemRTArogundadeFAAdebayoRARelationship between C-reactive protein and body mass index in Nigerians with type II diabetes mellitusNiger J Clin Med201243
- UnekITBayraktarFSolmazDThe levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese peopleClin Med Res20108289 9520660932
- BulloMGarcia-LordaPMegiasISalas-SalvadoJSystemic inflammation, adipose tissue tumor necrosis factor, and leptin expressionObes Res2003114525 53112690081
- FurukawaSFujitaTShimabukuroMIncreased oxidative stress in obesity and its impact on metabolic syndromeJ Clin Invest2004114121752 176115599400
- CerielloANew insights on oxidative stress and diabetic complications may lead to a “causal” antioxidant therapyDiabetes Care20032651589 159612716823
- ArnalichFHernanzALopez-MaderueloDEnhanced acute-phase response and oxidative stress in older adults with type II diabetesHorm Metab Res20003210407 41211069205
- Alizadeh DehnaviRde RoosARabelinkTJElevated CRP levels are associated with increased carotid atherosclerosis independent of visceral obesityAtherosclerosis20082002417 42318289549
- NordestgaardBGZachoJLipids, atherosclerosis and CVD risk: is CRP an innocent bystander?Nutr Metab Cardiovasc Dis2009198521 52419695857
- AbubakarSAOkubadejoNUOjoOOOladipoOOjiniFIDanesiMARelationship between admission serum C-reactive protein and short term outcome following acute ischaemic stroke at a tertiary health institution in NigeriaNiger J Clin Pract2013163320 32423771453
- MooradianADDyslipidemia in type 2 diabetes mellitusNat Clin Pract Endocrinol Metab200953150 15919229235
- FarmerJADiabetic dyslipidemia and atherosclerosis: evidence from clinical trialsCurr Diab Rep20088171 7718367002
- ValabhjiJElkelesRSDyslipidemia in type 2 diabetes: epidemiology and biochemistryBr J Diabetes Vasc Dis200333184 189
- MathuraKCVaidyaBGurbacharyaDLStudy of serum lipid profile in type 2 diabetic patients attending KMCTHNepal Med Coll J20057297 10016519073
- Barrett-ConnorEGrundySMHoldbrookMJPlasma lipids and diabetes mellitus in an adult communityAm J Epidemiol19821155657 6637081197
- ChampePCHarveyRALippincott’s Illustrated Reviews: Biochemistry3rd edPhiladelphia, PA, USALippincott Williams & Wilkins2005
- LadeiaAMAdanLCouto-SilvaACHiltnerAGuimaraesACLipid profile correlates with glycemic control in young patients with type 1 diabetes mellitusPrev Cardiol20069282 8816603826
- FranciscoGHernandezCChaconPMesaJSimoRFactors influencing CRP levels in the diabetic populationMed Clin (Barc)20051249336 337 Spanish15760600
- PickupJCMattockMBChusneyGDBurtDNIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome XDiabetologia199740111286 12929389420
- WenJLiangYWangFC-reactive protein, gamma-glutamyltransferase and type 2 diabetes in a Chinese populationClin Chim Acta20104113–4198 20319900432
- LiZGuoSQLiuWXA case-control study on risk factors of type 2 diabetes mellitus related chronic complications in Baoding cityZhonghua Liu Xing Bing Xue Za Zhi200930121292 1296 Chinese20193318